Last Updated: August 9, 2026

Litigation Details for Ericsson Inc. v. D-Link Corporation (E.D. Tex. 2010)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Ericsson Inc. v. D-Link Corporation
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation summary and analysis for: Ericsson Inc. v. D-Link Corporation (E.D. Tex. 2010)

Last updated: July 21, 2026

Litigation Summary and Analysis: Ericsson Inc. v. D-Link Corporation (6:10-cv-00473)

Ericsson Inc. sued D-Link Corporation (case No. 6:10-cv-00473) alleging patent infringement tied to wireless networking. The docket and public-reported outcomes for this specific matter are not provided in the input, and no verifiable filings (complaint, claim charts, Markman order, summary judgment, jury verdict, or final judgment) are available here to produce a complete, accurate litigation summary and legal analysis.

No case-specific litigation facts, procedural posture, asserted patents, claim constructions, defenses, settlement terms, or injunction damages structure can be stated reliably from the information provided.

Litigation posture

No verifiable details available in the provided material.

Key disputed issues typically litigated in this case (not case-specific)

No verifiable details available in the provided material.

Patents at issue

No verifiable details available in the provided material.

Motion practice and claim construction

No verifiable details available in the provided material.

Trial outcomes, remedies, and appeals

No verifiable details available in the provided material.

Settlement and licensing context

No verifiable details available in the provided material.

Competitive and commercial impact

No verifiable details available in the provided material.


Key Takeaways

  • Case-specific litigation events, asserted patents, claim construction, and outcomes cannot be confirmed from the provided input.
  • A litigation summary that names the asserted patents, procedural milestones, and disposition requires docket-level source facts that are not present here.

FAQs

What patents were asserted in Ericsson Inc. v. D-Link Corporation (6:10-cv-00473)?

Not stated in the provided input.

What was the court’s claim construction in the case?

Not stated in the provided input.

Did the case end in judgment, dismissal, or settlement?

Not stated in the provided input.

Was there an injunction or damages award for Ericsson in 6:10-cv-00473?

Not stated in the provided input.

Did D-Link challenge validity or enforceability (for example, obviousness or indefiniteness)?

Not stated in the provided input.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.